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Abstract
Some of the variety of Streptococcus pyogenes and Streptococcus dysgalactiae ssp. equisimilis (SDSE) M proteins act as
collagen-binding adhesins that facilitate acute infection. Moreover, their potential to trigger collagen autoimmunity has
been implicated in the pathogenesis of acute rheumatic fever and attributed to a collagen-binding motif called PARF
(peptide associated with rheumatic fever). For the first time we determine the rate of clinical isolates with collagen-binding
M proteins that use a PARF motif (A/T/E)XYLXX(L/F)N in a defined geographic region, Vellore in South India. In this region
both, incidence of streptococcal infections and prevalence of acute rheumatic fever are high. M proteins with PARF motif
conferred collagen-binding activity to 3.9% of 153 S. pyogenes and 10.6% of 255 SDSE clinical isolates from Vellore. The PARF
motif occurred in three S. pyogenes and 22 SDSE M protein types. In one of the S. pyogenes and five of the SDSE M proteins
that contained the motif, collagen-binding was impaired, due to influences of other parts of the M protein molecule. The
accumulated data on the collagen binding activity of certain M protein types allowed a reanalysis of published worldwide
emm-typing data with the aim to estimate the rates of isolates that bind collagen via PARF. The results indicate that M
proteins, which bind collagen via a PARF motif, are epidemiologically relevant in human infections, not only in Vellore. It is
imperative to include the most relevant collagen-binding M types in vaccines. But when designing M protein based vaccines
it should be considered that collagen binding motifs within the vaccine antigen remain potential risk factors.
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Introduction
Streptococcus pyogenes (group A streptococci, GAS) and Streptococcus
dysgalactiae subsp. equisimilis (herein abbreviated SDSE) cause
similar diseases in humans, which comprise pharyngitis, suppura-
tive skin infections, as well as invasive infections and streptococcal
toxic shock syndrome [1–3], the latter two causing high morbidity
and mortality. Severe immune sequelae, namely poststreptococcal
glomerulonephritis and acute rheumatic fever (ARF) can arise in
the wake of common S. pyogenes and SDSE infections of the throat
and skin [3–5]. Even though ARF has become rare in most
affluent populations, it remains an important health problem in
certain regions of the globe, particularly developing and newly
industrializing countries [6] as well as tropical territories [7,8].
S. pyogenes and the vast majority of SDSE isolates from human
infections possess emm genes [9–11], which encode for a prominent
pathogenic factor, the M protein. M proteins mediate adhesion to
host cells and connective tissues as well as cell invasion. Moreover,
these bacterial surface proteins act as antiphagocytic factors that
are crucial for defense against human innate immunity (for
references see [12–15]). High sequence variability in the N-
terminal region of M proteins forms the basis of emm genotyping
[16]. More than 200 distinct emm types are recorded in public
databases today. In addition to other streptococcal components
[17] M proteins are considered as potential vaccine antigens [18–
21]. However, a risk of serious side effects in humans, that may be
caused by molecular mimicry of coiled-coil proteins [1,12,22] or
other features of M proteins, complicates the development of M
protein based vaccines [19,22,23]. Some M proteins bind collagen;
a function that facilitates streptococcal infections by increasing
colonization of connective tissue [24–27]. Moreover, collagen
binding by certain M proteins elicits collagen autoimmunity,
which is also observed in ARF patients. This suggests collagen-
binding M proteins as triggers of this disease [25,28]. Their
interaction with collagen is mediated by a (A/T/E)XYLXXLN
amino acid sequence located in the N-terminal hypervariable
region of the M protein and referred to as PARF (peptide
associated with rheumatic fever) [28,29]. Notably, the PARF motif
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vaccination trial in which some of the vaccinees developed ARF or
similar symptoms [23]. Researching the interaction between M
protein and collagen promises a better understanding of its role in
streptococcal diseases and as a potential risk factor to be considered
in the design of M protein based vaccines. The relevance of
collagen-binding M proteins as triggers of autoimmunity, in vaccine
development or as virulence factors in acute infections depends on
their epidemiological role worldwide and in specific geographic
regions. This has motivated the following study.
Materials and Methods
Bacterial strains
S. pyogenes and SDSE isolates from human infections were
collected at the Christian Medical College, Vellore. The collection
comprised 153 S. pyogenes and 255 SDSE isolates from different
suppurative foci and invasive infections. Emm types of 254 of the
255 SDSE strains were described previously [11]. The additional
isolate was typed as stCQ343. None of isolates from Vellore was
included in previous studies on collagen-binding M proteins
[24,25,28,29]. The S. pyogenes M31 strains included in binding
experiments were not isolated in Vellore, but a courtesy of D. R.
Johnson from the University of Minnesota Medical School.
Sequencing of emm genes, sequence analysis, coiled-coil
prediction and alignment of M proteins
emm genes were amplified from streptococcal genomic DNA by
PCR and sequenced as described [11]. Sequence data were
processed and analyzed using the software BioEdit version 7.0.1
(Isis Pharmaceuticals). ‘‘PARF motif’’ designates the amended (A/
T/E)XYLXX(L/F)N consensus while ‘‘prototypical PARF motif’’
refers to the previously published (A/T/E)XYLXXLN consensus
[28]. ‘‘PARF-like’’ denotes sequences, which are similar to PARF,
but differ from the consensus in one of the conserved amino acids
(positions 1, 3, 4, 7 or 8). Own sequencing data, untrimmed M
protein sequences from the CDC (http://www.cdc.gov/ncidod/
biotech/strep/strepblast.htm; 1180 sequences) and GenBank
database [30] (648 sequences, 192 of them longer than 300 amino
acids, 103 of them comprising the N-terminal signal peptidase
cleavage site and the C-terminal LPSTG sequence) were analysed
for the presence of PARF motifs using the search function of
BioEdit for user-defined motifs (YLXXLN and YLXXFN).
ClustalW was used for multiple alignments [31]. Prediction of
parallel homo-dimeric coiled-coil structures in the N-terminal
sequences of M proteins was performed with Paircoils2 [32] at a
minimum search window length of 28.
Collagen binding assays
Collagen binding to streptococci was tested as described
previously [25]. Streptococci were grown overnight (37uC, 5%
CO2) in Tryptic Soy Broth (TSB, Becton Dickinson), washed and
resuspended in Phosphate Buffered Saline containing 0.05%
Tween 20 (PBST) to a concentration of 10
8 bacteria per ml. When
necessary, 750 ml of the bacterial suspension was treated with
195 U of hyaluronidase (AppliChem) for 2.5 h at 37uC shaking at
900 rpm, then washed and resuspended in 750 ml PBST. Bacterial
suspensions (250 ml) were incubated for 45 min with 30 ng
(100,000 cpm) of
125I-labelled collagen IV (from human placenta,
Sigma-Aldrich). Unbound collagen was removed by washing in
1 ml PBST before radioactivity of the pellet was quantified in a
Wallac 1470 Wizard gamma counter (PerkinElmer). Data were
analyzed using Microsoft Excel. Error bars indicate the standard
deviation of triplicate measurements.
Surface plasmon resonance (SPR) measurements
Recombinant M proteins stG2078, M55 and M31.5 were
produced and used in SPR measurements as described previously
[28]. Briefly, recombinant M proteins were injected for 2 min over
immobilized human collagen IV (400 RU) at a flow rate of 60 ml/
min. Data were analyzed using BiaEvaluation 3.0.
Results
Distribution of the PARF motif among streptococci from
Vellore, India
The epidemiological relevance of streptococcal M proteins with
collagen-binding PARF motif was investigated by sequencing the
emm genes of S. pyogenes and SDSE strains that were isolated from
human clinical infections in Vellore. The incidence of streptococ-
cal diseases and prevalence of ARF (1.0 per 1000 school children
[33]) is high in this geographic region. Emm types of S. pyogenes
isolates are given in table 1. The emm types of 254 of 255 SDSE
isolates have been reported earlier [11]. The 225
th was a type
stCQ343 isolate. Previously identified collagen-binding M proteins
with PARF motif [28,29] occurred in 1 of the 47 S. pyogenes emm
types (Table 1 and 2) and in 5 of the 45 emm types of SDSE clinical
isolates [11] from Vellore (Table 2). An additional 13 distinct emm
types, one from S. pyogenes and 12 from SDSE, coded for M
proteins with prototypical PARF sequences, which hitherto had
not been tested for collagen binding (Table 2).
Collagen binding of isolates with PARF(-like) motifs
All S. pyogenes isolates of the collection and representative SDSE
strains with previously untested PARF-positive M proteins were
examined for binding to human collagen IV (Table 2, Figure 1).
Strains with M proteins, bearing PARF-like sequences were also
included in the binding experiment. PARF-like sequences differ in
one of the motif’s conserved positions 1, 3, 4, 7 or 8 (Table 3) from
the previously published [29] or amended (A/T/E)XYLXX(L/
F)N consensus. Amendment is based on the collagen-binding
activity of M3.22, shown in this study (Table 2, Figure 2A). As the
streptococcal hyaluronic acid capsule is a potential collagen-
binding factor [25], protein-dependent collagen interactions were
verified in experiments with hyaluronidase treated bacteria.
Several streptococcal factors including M proteins bind collagens
[26,27,34,35]. However, based upon a cut-off value of 20% bound
ligand [29], only strains that expressed M proteins with a PARF
motif bound collagen IV after hyaluronidase treatment (Table 2).
The data indicated that PARF was pivotal for this interaction
between M protein and collagen that confers a high binding
capacity for collagen IV to the streptococci [28]. However, of the
16 newly discovered M proteins with PARF motif (14 distinct emm
types) that were examined in this study, only ten bound collagen
based upon the cut-off value (Table 2). Four types or groups of M
proteins did not bind collagen IV despite harboring PARF motifs
(Figure 3). The sequence ANYLKTLN occurred in three distinct
M proteins: stGM220, stG120.0 and stG120.1 (Figure 3D).
Interestingly, only the strain that expressed stG120.1 bound
collagen IV (56% bound ligand), while strains expressing stG120.0
or stGM220 did not (6% and 14% bound ligand). Expression of
the M protein by the tested strains was confirmed by examination
of their typical fibrinogen interaction (not shown). Sequences of
the collagen IV binding stG120.1 and of the non-binding stG120.0
and stGM220 protein were identical within the first 36 amino
acids that C-terminally flank the PARF motif. Identity between
stG120.1 and stGM220 extended to 125 amino acids. Lack of a C-
repeat (35 amino acids) after position 309 of the mature stG120.1
protein discriminates it from the two non-binding types stGM220
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similar to one another, differed considerably from the collagen-
binding M protein stG120.1 within the N-terminal region flanking
the PARF motif (Figure 3D). Both, sequence variations either N-
terminal or C-terminal from the PARF motif that distinguish the
collagen binding stG120.1 from the two non-binding M proteins
could govern the collagen binding activity of their PARF motif.
While M proteins of the other emm3 subtypes contain a
prototypical PARF motif (AEYLKGLN), in M3.22 the leucine
residue in position 7 is substituted by phenylalanine (AEYLKGFN).
Comparison of collagen IV binding by six individual emm3 isolates
revealeda reduced bindingcapacityoftypeemm3.22 ascomparedto
emm3.23 streptococci that harbor the prototypical PARF motif
(Figure 2A). Still, binding of more than 20% of the added collagen
IV by emm3.22 streptococci, indicated that position 7 of the PARF
motif tolerates substitution of leucine by phenylalanine without full
loss of the collagen binding function. Hence, position 7 is more
tolerant to amino acid substitution than previously known [29].
None of the 22 distinct emm types with PARF-like motifs (Table 3)
that were tested in this study was associated with collagen IV
binding. This provides further evidence for the pivotal role of the
consensus sequence for this interaction. In summary the experi-
ments demonstrate that PARF is the dominant, if not exclusive,
collagen-binding motif of M proteins, that endows streptococci with
a high binding capacity for collagen IV.
Collagen binding by recombinant M proteins
Previously, M3 was the only known PARF-positive M protein of
S. pyogenes that has been shown to bind collagen IV with high
affinity [25,28,36]. It remained to be investigated if PARF-
dependent collagen binding was limited to this single, though
epidemiologically important M type [37]. Like M3, S. pyogenes M
proteins M55 and M31 possessed a PARF motif. While M55
belongs to one of the most common S. pyogenes emm types isolated in
Pacific Island Countries and from Indigenous Australians [37],
M31 appears to be of minor epidemiological relevance worldwide
[37]. The M31 protein is typically found in S. pyogenes, but the
Vellore collection contained SDSE strains that expressed a M31.5
protein variant. Streptococci that expressed M31 or M31.5
exerted collagen-binding activity, while M55 carrying strains did
not (Figure 2B). To examine the interaction in an additional
experimental approach, collagen binding of recombinant proteins
M55 and M31.5 was compared using surface plasmon resonance
measurements (Figure 2C and D) in which both proteins bound to
immobilized human collagen IV in a concentration dependent
manner. M protein stG2078, that lacks a PARF motif, served as a
control and did not produce significant responses (,4 RU).
Compared to M31.5, M55 protein had a lower affinity for collagen
IV as indicated by apparent dissociation constants of 0.6 nM and
5 nM, respectively. The apparent dissociation constants are based
on the Langmuir model for 1:1 interactions. However, sigmoid
shapes of association curves indicated a higher complexity of the
binding mechanisms. In summary, the results identified M31
protein of S. pyogenes and its SDSE ortholog M31.5 as collagen-
binding M proteins and demonstrate a reduced collagen affinity of
M55. The latter explains the lack of high capacity collagen-
binding by emm55 S. pyogenes strains (Figure 2B).
Role of coiled-coil domains in collagen-binding M
proteins
M proteins form coiled-coil dimers [24,38–41]. Such a ternary
structure of the molecule may impact folding, accessibility and
thus the collagen binding function of the PARF motif. Therefore,
the position of the PARF motif was determined in relation to
Table 1. Emm-typing of clinical S. pyogenes isolates from
Vellore.
emm type no. of strains
emm100 4
emm102 3
emm104 4
emm105 1
emm108 7
emm11 13
emm110 6
emm111 1
emm112 9
emm113 2
emm12 1
emm15 3
emm18 2
emm25 2
emm28 5
emm3
a 6
emm42 2
emm44 2
emm49 6
emm53 1
emm55 2
emm56 4
emm58 1
emm60 3
emm63 7
emm66 1
emm68 1
emm69 6
emm74 2
emm77 7
emm80 3
emm82 6
emm85 2
emm88 1
emm89 1
emm92 3
emm93 4
st11014 1
st1398 8
st1731 1
st212 1
st2147 2
st2460 1
stD432 2
stKBN3 1
stKBN8 1
stNS554 1
aemm3.22 (3 isolates); emm3.23 (3 isolates).
doi:10.1371/journal.pone.0030122.t001
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coiled-coil formation was observed in close C-terminal proximity
to the PARF motif in all examined M proteins. In contrast, the
PARF motifs themselves form a sequence section with minimal
coiled-coil probability. Such interruption of the coiled-coil
structure may be a prerequisite for collagen binding. Influences
of the N-terminal M protein sequence on PARF activity may
depend on the ability of the N-terminal end to form a parallel
inter-chain coiled-coil domain (Figure 4B). The predictions
separated M proteins with and without an N-terminal coiled-coil,
but did not discern collagen-binding M proteins from inactive ones
(Figure 4B and C). Thus, the structural influences that govern the
collagen-binding activity of the PARF motif are more complex in
nature and seem independent of the M protein’s ability to form an
N-terminal inter-chain coiled-coil structure. Comparing coiled-coil
predictions for the full length M proteins (Figure 5) suggested that
the most drastic structural differences between the collagen IV
binding type stG120.1 and the non-binding types stG120.0 and
stGM220 lie N-terminal from the PARF motif. C-terminal from
the PARF motif, the sequences show a very similar coiled-coil
prediction over a stretch of 240 amino acids. Because of the
lacking C-repeat in stG120.1 (Figure 3D) coiled-coil-prediction of
the M proteins 164 most C-terminal residues is shifted relative to
stG120.0, but shows a similar curve shape. The coiled-coil
prediction analysis indicates that major structural differences,
which discern stG120.1 from the non-binding M proteins, are
limited to the N-terminal flanking region of PARF and to a distant
C-terminal part of the sequence. Since both could be the cause of
impaired collagen binding, the origin of inactivating influences
remains to be identified.
Global and regiospecific distribution of streptococci with
collagen-binding M proteins
The presented data show that a PARF motif is not a sufficient
but a necessary condition for high affinity binding of collagen IV
by streptococcal M proteins. In this study, combining PARF-based
prediction with experimental validation of collagen IV binding
activity disclosed that 3.9% of 153 S. pyogenes and 10.6% of 255
SDSE clinical isolates from Vellore possessed a collagen-binding
M protein with PARF. Taking previous studies into account a
large number of binding M types is now identified (Figure 1).
Searching the M protein database of the Centers for Disease
Control and Prevention (http://www.cdc.gov/ncidod/biotech/
strep/strepblast.htm) revealed an additional 14 M proteins with
PARF motif that remain to be tested for collagen binding (Table 4).
However, the most frequent PARF-positive M types worldwide
[37] and all except one M type with PARF motif that are reported
in the herein reanalyzed studies [8,42–47] are now tested for
PARF-dependent collagen interaction. This in turn allowed the
following estimations on global and region specific distributions of
collagen-binding M proteins with PARF motif. Worldwide, due to
a low epidemiological relevance of emm31, stKBN7, stM3, stPILA,
Table 2. PARF motifs of S. pyogenes and S. dysgalactiae subsp. equisimilis isolated in Vellore.
PARF motif
a collagen binding
b M protein No. of strains in the collection
S. pyogenes SDSE
AEYLKALN +
c stG10 2
AEYLKGLN +
d M3 3
ARYLETLN +
c stC5344 1
ARYLKRLN +
c stC-NSRT2.0 1
EAYLKRLN +
c stG2574 3
TQYLKRLN +
c stC2sk 3
+ stG97 2
ADYLKTLN + stC6746 1
AEYLKNLN + M31.5 2
AEYLKGFN
e + M3.22 3
AEYLRSLN + stG211.1 2
ANYLKELN 2 stC46 1
2 stCK401 2
ANYLKTLN + stG120.1 2
2 stG120.0 1
2 stGM220 1
ARYLKKLN + stG351 1
ATYLKELN 2 M55 2
TEYLKRLN 2 stGrobn 5
TEYLKSLN + stCQ343 1
+ stG211.0 2
TKYLKRLN + stC922 4
aAmino acids conserved or typical for PARF are shown in bold.
bPositive strains bound more than 20% of the added collagen IV before and after hyaluronidase treatment.
c, dCollagen binding of this M protein is shown in [29] or [28], respectively.
eThe motif did not fully match the previously reported consensus [28] but was positive for collagen binding.
doi:10.1371/journal.pone.0030122.t002
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pyogenes strains that possess collagen-binding M proteins with
PARF motif was largely determined by emm3 strains. Based on the
data of Steer and colleagues [37] it can be estimated that
worldwide about 7% of the S. pyogenes strains possessed a collagen-
binding M protein with PARF. In different geographic regions the
estimated rate of S. pyogenes strains with active PARF motif ranged
from less than 2% in Asia over 3.5% in Africa and 7.5% in the
established market countries of Europe, North America, Australia,
Japan and Hong Kong to more than 10% in the Middle East. A
rate of 26.5% emm3 strains in pediatric patients in China that was
documented for the years 1993–1994 and a subsequent drastic
decrease until 2005–2006 documents the rate’s potential for high
temporal variability [42]. PARF motifs conferred collagen binding
activity to a variety of distinct M proteins of SDSE (Table 2,
Figure 1). Analysis of studies on SDSE, which were not limited to
invasive cases of infection, revealed rates of 4.4%, 4.7% and
13.8% in Thailand [43], Norway [44] and Portugal [45],
Figure 1. Known S. pyogenes and SDSE collagen-binding M proteins harboring PARF. M protein designations are given on the left. The
PARF motif is shown in black letters and eleven flanking amino acids on both the N-terminal and C-terminal side in grey letters. Collagen-binding
activity is indicated on the right with ‘+’ when positive or with ‘2’ when negative. Numbers flanking the sequence indicate its position within the
mature protein. Amino acids conserved or typical for PARF are shown in bold. Identical amino acids (*), conserved substitutions (:), and semi-
conserved substitutions (.) are indicated as determined by multiple alignment. Amino acids with basic side chains in positions 2, 5 or 6 are
highlighted in grey.
doi:10.1371/journal.pone.0030122.g001
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proteins. For a study from Japan [46] the estimated rate ranged
between 13.8% and 14.5% since collagen binding activity of
stG4974 remains untested (Table 4). Based on community
surveillances, collagen-binding M proteins with PARF motif
occurred in 8.7% of the strains from Mumbai school children
[47] and in 5.9% of the strains isolated from Indigenous
Australians [8]. Collectively, this retrospective analysis of emm
typing data indicates that collagen-binding M proteins with PARF
motif are frequently involved in clinical cases of S. pyogenes and
SDSE infection both, in Vellore and on a global scale.
Discussion
S. pyogenes is an exclusively human pathogenic bacterium that
exerts host specific interactions during infection. Animal models
simulate its pathogenesis only partially, particularly the complex
processes underlying streptococcal sequelae. As a consequence,
deeper investigations on the role of collagen-binding M proteins in
streptococcal clinical infections and sequelae require additional
approaches, comprising the analysis of clinical data and causative
strains collected from human patients. These clinical approaches
benefit from comprehensive knowledge about the circulating
streptococcal strains expressing collagen-binding M proteins.
Presence of a prototypical PARF motif (A/T/E)XYLXXLN in
the variable N-terminal amino acid sequence of M protein was
suggested as predictive of a collagen binding function [28,29].
Screening of the complete S. pyogenes collection in this study
demonstrated that the occurrence of a PARF motif (A/T/
E)XYLXX(L/F)N in the M protein was not a sufficient but a
necessary condition for its collagen-binding activity (Figure 1) that
comprises high affinity binding to collagen IV. Supportive to
earlier results [28,29], the positions 2, 5, and 6 of the PARF motifs
were preferentially occupied by charged amino acids, most often
with basic side chains (Figure 1). Collagen binding of M proteins
Figure 2. Collagen binding to M3, M31 and M55. (A) S. pyogenes strains that expressed the M protein M3.22 (white bars) or M3.23 (black bars)o r
(B) S. pyogenes strains that expressed M protein M55 (white bars) or M31 (black bars) and a SDSE strains that expressed M31.5 (grey bar) were
compared for binding of collagen IV. Strain designations are indicated in the abscissa. The binding capacity was expressed as the bound percentage
of added radiolabelled collagen IV. The average of three experiments is depicted with standard deviation. In (A) PARF sequences of the M proteins are
shown above. (C and D) SPR sensograms of the interaction between immobilized human collagen IV (400 RU) and M protein M31.5 (C) or M55 (D)a s
analyte in the liquid phase were recorded upon injection of the analyte in concentrations that are indicated on the right in nM. Injections started at
t=0 s and ended at t=120 s.
doi:10.1371/journal.pone.0030122.g002
Table 3. PARF-like motifs found in M proteins of S. pyogenes
and S. dysgalactiae subsp. equisimilis isolated in Vellore.
PARF-like motif
a M protein
AKLLEELN stG2078
DRYLDKLF stG5420
EKNLEALN stG840
ERDLKDLN stC6979
INYLKGLN stC1741
ISYLKDLN stKNB8
LDYLKKLD M66, M68, M92
b, M104,
M110
b, st1389.1, st1389.2
LNYLKKLD M110
b
LTYLKKLD M92
b
PEDLKRLN stGL265.1
PEDLKSLN stGL265.0
RHYLKKLD M28, M88, st1731
RHYLKQLD stNS554
RHYLRQLD M77, M102, M112, st212
VNYVKILN stG7882
aAmino acids conserved or typical for PARF are shown in bold.
bProteins M110 and M92 harbored two PARF-like motifs.
doi:10.1371/journal.pone.0030122.t003
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experimental evidence for the tolerance of threonine in position 1
of the PARF motif (Figure 1). Moreover, a certain tolerance of
position 7 for phenylalanine substitution was observed (Figure 2A),
which led to the amended PARF consensus described above. Due
to potential interference of other parts of the M protein with the
collagen-binding motif, conclusions on the effect of isoleucine
substitution in position 1 were not possible (Table 3). Conspicu-
ously, the first amino acid following the PARF consensus was
conserved (Figure 1). This suggests that the acidic side chains of
aspartic or glutamic acid may contribute to the collagen-binding
activity of the M proteins. In earlier experiments with synthetic
peptides substitution of the aspartic acid by alanine had no
influence on the collagen interaction [28]. Therefore, it is more
likely that the acidic residue is important for the fold of the binding
motif within the M protein rather than being a direct contact site
for the collagen molecule. The fourth position following the
collagen-binding motif was occupied by either glutamine or
glutamic acid; amino acids of different character but similar
dimensions. Contributions of additional amino acids to the
collagen-binding motif of M proteins appear likely and deserve
further investigation.
The epidemiological significance of collagen-binding M proteins
is demonstrated by the presented data. Regionally and temporally
the rates of collagen-binding M proteins that use a PARF motif
differed considerably, exceeding 10% for both, S. pyogenes or SDSE
in several studies [37,42,45,46]. Previous [25,28,29] and herein
presented experimental data on more than 100 different M protein
types locate all known collagen-binding PARF motifs within the
first 70 amino acids of the mature M protein. Searches in the CDC
and GenBank database disclosed 14 more M proteins with PARF
sequences (Table 4), but none of the PARF motifs was located
more C-terminally than amino acid number 70. The GenBank
database included 103 full-length sequences of mature M proteins,
representing a great variety of C-terminal M protein sequences.
Still, due to limited C-terminal sequence information particularly
in the CDC database and due to the presumable existence of
unknown M types, it cannot be excluded that some PARF-positive
M proteins remain unidentified. Therefore, the herein presented
reexamination of previous emm-typing studies, delivered estimated
Figure 4. Prediction of N-terminal coiled-coil structures in PARF-positive M proteins. (A) Coiled-coil structure prediction for the N-terminal
sequences of the PARF-positive M proteins is given as P-scores vs. the amino acid position relative from the PARF motif with the first amino acid of
the motif being position 1. The figure shows the superposition of all curves without indicating protein designations, however, collagen-binding M
proteins are shown in blue and non-binding M proteins are shown in red. Single curves for all M proteins are provided as a supplementary figure
(Figure S1). The position of the PARF motif is highlighted in light blue.Ablack dashed line indicates the threshold value for coiled-coil prediction.
Values below 0.025 indicate a coiled-coil structure. The prediction separates the M proteins into two classes; one class with (B) and one without (C)a n
N-terminal coiled-coil domain. They are shown in schematic representations that are not drawn to scale. B and C are not based on structural data
other than coiled-coil prediction. The PARF motif is highlighted in red. The C-terminal end is labelled (-COOH).
doi:10.1371/journal.pone.0030122.g004
Figure 3. M proteins with predicted PARF motifs that did not bind collagen. Protein sequences of four types or groups of M proteins that
harbored a prototypical PARF motif but had members that did not bind collagen (A–D). M protein designations are given on the left together with
the results of collagen IV binding experiments that are given in brackets with ‘+’ for binding and ‘2’ for non-binding proteins. Numbers that flank the
sequence indicate its position within the mature M protein without signal peptide. In C and D identical amino acids (*), conserved substitutions (:),
and semi-conserved substitutions (.) in two or three compared sequences are marked below. Amino acids characteristic for PARF are printed in bold.
In D residues that distinguish the collagen-IV binding stG120.1 from the non-binding stG120.0 and stGM220 are highlighted in grey.
doi:10.1371/journal.pone.0030122.g003
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be associated with some, though reasonable, uncertainty.
The presented work is limited to investigations on the PARF-
dependent M protein interaction that endows streptococci with a
high binding capacity for collagen including collagen IV.
Nevertheless, it needs to be mentioned that other streptococcal
collagen-binding factors exist [25–27,34]; among them M1
protein, that does not have a PARF motif but binds collagen I
and VI with high and collagen IV with low affinity. Interestingly,
M1 binds to the non-collagenous moiety of collagen VI [26,27].
The observed differences in binding specificities between PARF-
positive and PARF-negative collagen binding M proteins suggest
that they have dissimilar functions during infection. Even so, the
epidemiological relevance of collagen-binding M proteins in
human infections appears to be higher than suggested by herein
presented data on PARF and requires further examination.
Rapidly progressing invasive infections and high incidence of
sequelae under poor socioeconomic conditions nurture the need
for a vaccine against these bacteria. Several M protein and non-M
protein vaccines are in development [17–21]. Due to the obvious
epidemiological relevance of certain PARF-positive emm types like
emm3 [37] it is imperative to include them in an efficacious
streptococcal vaccine. Although suspected to induce the diseases it
should prevent [1,21,23], the M protein remains under consider-
ation as a vaccine candidate [18–21]. One strategy to prevent the
hazardous side effects of this antigen is to exclude or inactivate the
pathogenic motifs of the M protein while preserving the epitopes
that induce protective immune responses [19,21]. This requires a
profound knowledge about all confirmed or potentially auto-
immunogenic motifs, including the collagen-binding site. PARF
motifs reside in the N-terminal portions of M proteins that induce
type-specific protective immunity and that are considered as
promising vaccine antigens [19–21,48]. With respect to the
potential to induce autoimmunity it seems advisable to inactivate
the PARF motifs in vaccine antigens, preferably with minimal
changes in protein sequence and structure.
The existence of PARF-bearing M proteins that are inactive
regarding collagen binding is a novel observation and a paradigm
for the limits of purely sequence based functional predictions.
However, their identification creates an opportunity to study the
structural requirements for PARF activity and for its inactivation.
Comparing amino acid sequences and coiled-coil structure
predictions of PARF-bearing M proteins suggests that N-terminal
sequences flanking the PARF motif or more distant C-terminal
sequence variations can exert structural influences that interfere
with collagen binding. The most drastic differences up to the
ternary structure of these M proteins lie N-terminally from the
Figure 5. Prediction of coiled-coil structures in PARF-positive M proteins. Coiled-coil structure prediction for the N-terminal sequences of
the PARF-positive M proteins stG120.0 (red dotted line), stG120.1 (light blue solid line) and stGM220 (black dotted line) is given as P-scores vs. the amino
acid position relative from the PARF motif with the first amino acid of the motif being position 1. Isolates with M protein stG120.1 bind collagen IV,
while strains that carry one of the other two M proteins do not. The position of the PARF motif is highlighted in light blue.Ablack dashed line
indicates the threshold value for coiled-coil prediction. Values below 0.025 indicate a coiled-coil structure.
doi:10.1371/journal.pone.0030122.g005
Table 4. Untested additional M proteins with PARF-like
motifs found in the CDC and GenBank database.
Species PARF motif
a M protein
S. pyogenes AEYLKGLN st0775
st1692
st3720
stM3
st4050
ADYLKKLN stPILA
TKYLKELN stKNB7
SDSE AQYLKKLN stCN204
TQYLKSLN stG354
AQYLRELN stG1750
AEYLQRLN stG4974
ARYLRELN stG5063
TNYLKTLN stGLP3
ADYLYRLN stGM203
aAmino acids conserved or typical for PARF are shown in bold.
doi:10.1371/journal.pone.0030122.t004
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N-terminal coiled-coil domain and collagen-binding activity was
observed, indicating that other perhaps more complex or even
individual structural influences act on the PARF motif. Therefore,
a study to unveil the structural biological details of the interaction
between collagen and M proteins needs a careful design; an effort
that could be rewarded with therapeutic substances that interfere
with streptococcal colonization, with a better understanding of
autoimmunity induced by streptococci and with safe antigens for
vaccines against these pathogens.
Supporting Information
Figure S1 Prediction of coiled-coil structures in PARF-
positive M proteins. Coiled-coil structure prediction for the N-
terminal sequences of the indicated PARF-positive M proteins is
depicted as P-scores vs. the amino acid position relative from the
PARF motif with the first amino acid of the motif being position 1.
Scores below 0.025 indicate a coiled-coil structure. The position of
the PARF motif is highlighted in light grey.
(PDF)
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